Which Workshop Is The Best Fit For You?
This year introduces our first two-tracked agenda, including a choice of two tracks on our Pre-Conference Workshop Day.
Hear the latest advancements in peptide innovation across in-depth workshops solving emerging peptide challenges, from leveraging AI for peptide design, harnessing new tools from mRNA and phage display for peptide screening, leveraging peptides for drug conjugation and optimizing the peptide analytical toolbox for effective translatability.
Whether your focus is in Drug Discovery or Formulation & CMC, take this short quiz to see which workshops would suit you best:
Question 1 - Complete this statement: In 2026, my biggest priority is…
a) Focused on peptide discovery R&D from screening to hit identification and lead candidate selection
b) Focused on improving oral bioavailability with better formulation and analytical strategies for peptide drug development
Question 3 - Complete this statement: When it comes to peptide therapeutics, what I need most is…
a) Ways to effectively to design peptides, enabling chemical optimization of their properties
b) Ways to improve the precise targeting of peptides and reduce the potency of cytotoxic drugs
Question 2 - Complete this statement: 2) The challenge I most need to solve right now is how to…
a) Accelerate peptide design, activity prediction, and optimized screening including using mRNA and phage display technologies
b) Overcome the stability, ligand binding specificity and analytical PKPD to translate across model systems
Question 4 - Complete this statement: For 2026, I’m more excited about the peptide field because of how…
a) Artificial intelligence and machine learning are reshaping peptide-based drug discovery
b) Next generation use-cases of peptides such as Peptide-Drug Conjugates becoming a promising delivery strategy
Your Results... (drum roll please)
Mostly A’s — You belong in:
- Workshop A – Artificial Intelligence for Peptide Design
- Workshop B – Screening Methods
Companies attending include:
Mostly B’s — You belong in:
- Workshop C – Peptide-Drug Conjugates
- Workshop D – Analytical Development
Companies attending include:
Testimonials
This meeting presents an opportunity to get the thought leaders in the world of peptide therapeutics together to share the contributions they are making to our industry. I believe that others will benefit from hearing our story and how we advanced multiple peptides into the clinic over the past 5 years; and we will benefit from learning similar info from our peers.
Barry Kappel, Sapience Therapeutics
As we continue to unlock the potential of peptide therapeutics as a validated modality, it is invaluable to connect with the leading experts in the field to share our learnings and ensure our collective success in delivering these transformative therapies into the clinic and toward meaningful impact for patients.
Shelley Allen, Abbvie
I see the Summit as a force multiplier. Peptide therapeutics sit at a pivotal point—between small molecules and biologics. Participating enables us to accelerate translation by aligning on design rules, delivery strategies, and CMC best practices; stress-test our assumptions with peers and regulators; and forge the right partnerships across academia, biotech, and large pharma.
Maria Fawaz, Merck & Co
The Summit will be an excellent opportunity to hear from thought leaders about advances in peptide-based therapeutics, the increasing importance of this modality, and where the field is heading in the next few years.
David Earp, Circle Pharma
Attending Companies Include